Metabolic (cytoprotective) therapy of menopausal disturbances
The paper presents modern views on cardiovascular aspects of menopause and metabolic therapy of menopausal disturbances with meldonium (Mildronate®). The role of estrogen deficiency in climacteric disturbance development, key pathogenetic mechanisms of menopausal metabolic syndrome (MS), and relevan...
| Published in: | Кардиоваскулярная терапия и профилактика |
|---|---|
| Main Authors: | S. N. Tolstov, V. B. Mychka |
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2011-06-01
|
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1835 |
Similar Items
Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
by: E. V. Tishina, et al.
Published: (2011-06-01)
by: E. V. Tishina, et al.
Published: (2011-06-01)
Direct renin inhibitor aliskiren in women with menopausal metabolic syndrome and arterial hypertension
by: Yu. V. Zhernakova, et al.
Published: (2011-08-01)
by: Yu. V. Zhernakova, et al.
Published: (2011-08-01)
Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
by: V. V. Trusov, et al.
Published: (2007-08-01)
by: V. V. Trusov, et al.
Published: (2007-08-01)
Metabolic syndrome, not menopause, is a risk factor for hypertension in peri-menopausal women
by: Gyu Chul Oh, et al.
Published: (2018-10-01)
by: Gyu Chul Oh, et al.
Published: (2018-10-01)
MAIN THERAPEUTIC PRINCIPLES IN PREMENOPAUSAL WOMEN
by: S. N. Tolstov, et al.
Published: (2011-12-01)
by: S. N. Tolstov, et al.
Published: (2011-12-01)
“Female issue” in cardiology
by: V. B. Mychka, et al.
Published: (2010-08-01)
by: V. B. Mychka, et al.
Published: (2010-08-01)
Hypertension and menopause
by: O. D. Ostroumova, et al.
Published: (2019-09-01)
by: O. D. Ostroumova, et al.
Published: (2019-09-01)
New possibilities of arterial hypertension therapy for women in menopause
by: V. N. Shishkova, et al.
Published: (2021-06-01)
by: V. N. Shishkova, et al.
Published: (2021-06-01)
Metabolic Disorders in Menopause
by: Hye Gyeong Jeong, et al.
Published: (2022-10-01)
by: Hye Gyeong Jeong, et al.
Published: (2022-10-01)
Menopause: focus on additional therapy opportunities. Literature review
by: О. О. Єфіменко, et al.
Published: (2020-07-01)
by: О. О. Єфіменко, et al.
Published: (2020-07-01)
Menopausal metabolic syndrome after hysterectomy
by: V. I. Podzolkov, et al.
Published: (2005-12-01)
by: V. I. Podzolkov, et al.
Published: (2005-12-01)
Metabolic Syndrome and Menopause: The Impact of Menopause Duration on Risk Factors and Components
by: Erdoğan K, et al.
Published: (2024-07-01)
by: Erdoğan K, et al.
Published: (2024-07-01)
Gaining weight and components of metabolic syndrome in the period of menopause
by: Simoncig-Netjasov Aleksandra, et al.
Published: (2008-01-01)
by: Simoncig-Netjasov Aleksandra, et al.
Published: (2008-01-01)
SPECIFICS OF METABOLIC SYNDROME PATHOPHYSIOLOGY IN WOMEN AT DIFFERENT PHASES OF CLIMACTERIC PERIOD
by: V. B. Mychka, et al.
Published: (2015-04-01)
by: V. B. Mychka, et al.
Published: (2015-04-01)
Cardiovascular prevention in peri- and postmenopausal women
by: N. A. Voychenko, et al.
Published: (2011-06-01)
by: N. A. Voychenko, et al.
Published: (2011-06-01)
Dynamics of lipid and carbohydrate metabolism parameters in women with menopausal metabolic syndrome, receiving glucose-lowering therapy
by: A. V. Starodubova, et al.
Published: (2011-08-01)
by: A. V. Starodubova, et al.
Published: (2011-08-01)
BLOOD PRESSURE VARIABILITY AND THE CONDITION OF TARGET ORGANS IN MENOPAUSAL WOMEN
by: S. N. Tolstov, et al.
Published: (2014-06-01)
by: S. N. Tolstov, et al.
Published: (2014-06-01)
Algorithms for prescribing menopausal hormone therapy in different periods of menopause
by: T.F. Tatarchuk, et al.
Published: (2022-08-01)
by: T.F. Tatarchuk, et al.
Published: (2022-08-01)
Alternative therapy for the treatment of menopausal disorders: effective ways to correct
by: Z. N. Efendieva, et al.
Published: (2018-04-01)
by: Z. N. Efendieva, et al.
Published: (2018-04-01)
Association Between Menopause and Metabolic Syndrome in the Registration Phase Data of Tabari Cohort Population
by: Seyed-Robabe Babaei, et al.
Published: (2025-05-01)
by: Seyed-Robabe Babaei, et al.
Published: (2025-05-01)
Current approaches to alternative therapy in menopausal syndrome (a review)
by: A. G. Mamontova, et al.
Published: (2018-08-01)
by: A. G. Mamontova, et al.
Published: (2018-08-01)
Specifics of prescribing menopausal hormonal therapy in patients with the anamnestic endometriosis
by: M. I. Yarmolinskaya, et al.
Published: (2021-01-01)
by: M. I. Yarmolinskaya, et al.
Published: (2021-01-01)
Metabolic disorders associated with early menopause in the female population of Eastern Siberia: results of a cross-sectional study
by: Ia. G. Nadeliaeva, et al.
Published: (2021-11-01)
by: Ia. G. Nadeliaeva, et al.
Published: (2021-11-01)
WAYS OF MENOPAUSAL HORMONAL THERAPY IN CORRECTION OF METABOLIC DISORDERS AND ANGIOPROTECTION IN POSTMENOPAUSAL WOMEN
by: V. Yu. Khripaeva, et al.
Published: (2016-04-01)
by: V. Yu. Khripaeva, et al.
Published: (2016-04-01)
Hubungan Tingkat Spiritualitas Wanita Menopause dengan Sindrom Menopause pada Daerah Pedesaan
by: Intan Indah Sari, et al.
Published: (2021-11-01)
by: Intan Indah Sari, et al.
Published: (2021-11-01)
Interpretation on the 2023 Chinese Menopause Symptom Management and Menopausal Hormone Therapy Guidelines
by: CHEN Rong
Published: (2023-05-01)
by: CHEN Rong
Published: (2023-05-01)
To what extent the weight changes impact the risk of hypertension among menopausal women: insights from Tehran lipid and glucose study
by: Marzieh Saei Ghare Naz, et al.
Published: (2024-02-01)
by: Marzieh Saei Ghare Naz, et al.
Published: (2024-02-01)
INFLUENCE OF MENOPAUSE ON BLOOD PRESSURE DIPPING IN WOMEN WITH METABOLIC SYNDROME: A CASE-CONTROL STUDY
by: D. A. Anichkov, et al.
Published: (2015-12-01)
by: D. A. Anichkov, et al.
Published: (2015-12-01)
V International expert forum on menopausal hormone therapy
by: L.R. Agababyan, et al.
Published: (2024-03-01)
by: L.R. Agababyan, et al.
Published: (2024-03-01)
Health perception in menopausal women
by: Del Sueldo M, et al.
Published: (2018-10-01)
by: Del Sueldo M, et al.
Published: (2018-10-01)
Pathogenetic rationale for prescribing menopausal hormone therapy for systemic sclerosis
by: T. S. Panevin, et al.
Published: (2022-11-01)
by: T. S. Panevin, et al.
Published: (2022-11-01)
Patterns of clinical presentation of climacteric syndrome and total body composition in women with menopausal metabolic syndrome
by: Z. E. Shulukian, et al.
Published: (2021-10-01)
by: Z. E. Shulukian, et al.
Published: (2021-10-01)
Perimenopause period and menopause: cardiovascular and metabolic risks
by: V. H. Siusiuka, et al.
Published: (2024-10-01)
by: V. H. Siusiuka, et al.
Published: (2024-10-01)
The Effect of Menopause on Antipsychotic Response
by: Alexandre González-Rodríguez, et al.
Published: (2022-10-01)
by: Alexandre González-Rodríguez, et al.
Published: (2022-10-01)
Echocardiographic Evaluation of Diastolic Dysfunction among Menopausal Women: A Cross-sectional Study
by: E Thirumurugan, et al.
Published: (2022-11-01)
by: E Thirumurugan, et al.
Published: (2022-11-01)
Endometriosis and menopause—management strategies based on clinical scenarios
by: Ivika Jakson, et al.
Published: (2023-10-01)
by: Ivika Jakson, et al.
Published: (2023-10-01)
The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis
by: Yimeng Gu, et al.
Published: (2024-01-01)
by: Yimeng Gu, et al.
Published: (2024-01-01)
Thyroid dysfunction in women with a menopausal syndrome
by: Oksana Pavlovska, et al.
Published: (2024-10-01)
by: Oksana Pavlovska, et al.
Published: (2024-10-01)
Prevalence of menopausal symptoms and attitudes towards menopausal hormone therapy in women aged 40–60 years: a cross-sectional study
by: Jie Lu, et al.
Published: (2023-09-01)
by: Jie Lu, et al.
Published: (2023-09-01)
Cognition, Mood and Sleep in Menopausal Transition: The Role of Menopause Hormone Therapy
by: Giulia Gava, et al.
Published: (2019-10-01)
by: Giulia Gava, et al.
Published: (2019-10-01)
Similar Items
-
Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
by: E. V. Tishina, et al.
Published: (2011-06-01) -
Direct renin inhibitor aliskiren in women with menopausal metabolic syndrome and arterial hypertension
by: Yu. V. Zhernakova, et al.
Published: (2011-08-01) -
Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
by: V. V. Trusov, et al.
Published: (2007-08-01) -
Metabolic syndrome, not menopause, is a risk factor for hypertension in peri-menopausal women
by: Gyu Chul Oh, et al.
Published: (2018-10-01) -
MAIN THERAPEUTIC PRINCIPLES IN PREMENOPAUSAL WOMEN
by: S. N. Tolstov, et al.
Published: (2011-12-01)
